RPC-714

Weapon-Vampires

tagnone

Registered Phenomena Code: 714

Item Type: Other (Diseases)

Lethality Rating: Orange/Utility

Overseeing Personnel: Dr. Emil Kaufmann

Hazard Types:Additional Properties:

Ballistic

Transmutation

Mind-Regression

Microscopic

Organic

Regenerative

Abstract:

RPC-714, otherwise known as Carcinmetalloplasia,¹ is a cancerous disease characterized by the ability of subjects to transform their bones into fully functional weapons. This condition results from years of study by the Church of Malthus to create a series of "Weapon-Vampires."

Safe Handling and Usage:

RPC-714 stem cells are preserved in dedicated storage units with an internal temperature of -80°C. Biology department staff assess the stem cells for genetic stability weekly. Candidates for RPC-714-1 must conduct comprehensive physical and mental health to ensure the subjects' suitability to handle RPC-714 injection.

RPC-714-1 subjects are confined in standard humanoid containment chambers equipped with sedative morphine implants for the safety of the subject and on-site personnel. The subject must follow a strict dietary protocol and regular medical and psychological evaluations.

fig. 1.1: Carcinmetalloplastic Osteoid under an electron microscope

fig. 1.2: X-ray of a Longsword-variant RPC-714-1 instance mid-transformation.

Description:

RPC-714 is a modified cell infection that morphs a human subject’s bones through the synthesis of metallic compounds on the bone matrix. This process results in the formation of a dense and compact structure called the Carcinmetalloplastic Osteoid (fig. 1.1). This transformation condenses the subject’s skeletal and muscular mass, heightening their body’s ability to rapidly regenerate through the temperament of malignant cell proliferation.

RPC-714 is caused by an injection of osteoprogenitor cells² carrying RPC-714 RNA templates into the subject's spinal cord. Depending on which bone RPC-714 targets, full systemization may take from 2 weeks to 6 months. Completely synthesized subjects are designated as RPC-714-1.

In the event that RPC-714-1 reaches a certain threshold of pain, the subject activates the trigger-phase. The trigger-phase is a transformational phase where the subject’s bones expand, fracture, and transform into a variety of sharp, pointed, or blunt objects that replicate the appearance of existing weapons (fig. 1.2). Once the trigger-phase is over, RPC-714 will morph back to its original form, suffering severe hypovolemia³ in the process.

The trigger phase shifts the structure of the brain. This brain deformation heightens RPC-714-1’s aggression and contorts their hypothalamus and pituitary gland, resulting in involuntarily laughing and/or crying.

The trigger-phase necessitates a substantial amount of biomass.⁴ As a consequence of its increased hunger, a significant portion of RPC-714-1 instances are innately driven by an insatiable craving for human flesh and blood.⁵

[+] List of variant templates

Template	Type	Designation
Control template	N/A	714-v(2+)-00
Needle	teeth	714-v(3+)-01
Dagger	teeth, metacarpus, phalanges	714-v(3+)-02
Spear	radius, ulna	714-v(3+)-03
Sabre	clavicle, carpus, metacarpus	714-v(4+)-04
Longsword	clavicle, carpus, metacarpus, fibula	714-v(4+)-05
Zweihander	clavicle, radius, ulna, tibia	714-v(5+)-06
Axe	clavicle, radius, ulna, tibia	714-v(3+)-07
Mace	clavicle, carpus, metacarpus, fibula	714-v(4+)-08
Warhammer	clavicle, radius, ulna, tibia	714-v(6+)-09
AK-47	clavicle, carpus, metacarpus, fibula	714-v(6+)-10
M16/M4/AR-15 and derivatives	clavicle, radius, ulna, tibia	714-v(6+)-11
Uzi	clavicle, carpus, metacarpus	714-v(7+)-12
M40	humerus, femur	714-v(8+)-13
Crossbow	clavicle, radius, ulna, tibia	714-v(4+)-14
…	…	…

Addendum 714.1: Biological Analysis

[+] 714.2 Biological Analysis

[-] 714.2 Biological Analysis

Biology Department

Overview of the Physiology of RPC-714

(a) Preface: RPC-714, also known as Carcinmetalloplasia, is a phenomenon characterized by the transformation of bone into a metal-like substance. This document aims to provide a comprehensive explanation of the physiology RPC-714.

(b) Synthesis: To achieve a full synthesis, a dose of 4.0 million stem cells per 60 ml is required. These cells are injected into the hypothalamus to help facilitate the distribution of RPC-714 throughout the body.

The hypothalamus enables RPC-714 to modify the subject's thyroid gland, which is responsible for triggering the subsequent trigger-phase.

The trigger-phase activates when hormones such as cortisol and adrenaline are released into the bloodstream and perfuse into a targeted bone.

(d) Osteogenesis: During the trigger-phase, the subject's bones undergo expansion, fracture, and transformation, facilitated by osteoclasts.⁶ These osteoclasts were modified to possess a specialized acidic enzyme that targets the metallic compounds found in the Carcinmetalloplastic Osteoid.

By secreting the acidic enzyme, the modified osteoclasts dissolve and expand the bones as the metal components are released. This process triggers osteoblastic⁷ rearrangement and regeneration, leading to the formation of skeletal weapons observed in RPC-714-1 instances.

Considering the heat generated during rapid weapon creation and disassembly, the osteoclasts and osteoblasts were engineered with a more stable protein structure to help mitigate the effects of hyperthermia.

(e) Neuroplasticity: Carcinmetalloplasia induces structural modification in the brain, specifically in the hypothalamus, pituitary gland, and brainstem.

Summary: The synthesis of RPC-714 involves the injection of osteoprogenitor cells to facilitate its distribution and modification of the thyroid gland via the hypothalamus. The trigger-phase triggers bone expansion and transformation through the action of modified osteoclasts, while neuroplasticity affects key brain structures, leading to cognitive and behavioral changes observed in RPC-714-1 instances.

Addendum 714.2: Test Log

[+] Experiment Log 714/16

[-] Experiment Log 714/16

	Anomaly Experimentation Team Official Test Log
	Location: Site-██	Date: 11/11/2020
	Test Subject(s): (4) Adult Pigs	Classification level: 2
	Researchers: Senior Researcher Dr. Thomas Christen, Dr. William Woodsworth, Dr. Samuel Shelley, Peter Jacobsen

Experiment 714/16

Resources: (4) Adult Pigs, (4) RPC-714-v5

Purpose: To observe the effect of Carcinmetalloplastic stem cells in animal models.

Procedure: 4 different variants of RPC-714-v5 were injected into each of the four pigs, following the established protocol. The pigs were closely monitored for any physical changes or alterations in bone density and muscle development over time. After fully synthesizing, the pigs are to be shocked into a trigger-phase.

Log: It was observed that the pigs' bone density increased significantly following the injection of the Carcinmetalloplastic Stem Cells. Additionally, their bones and muscles exhibited noticeable growth and increased mass (fig. 2.1).

However, despite these physiological changes, the pigs did not display the expected response when subjected to the trigger-phase stimulus. During the shock stimulus, the pigs exhibited minor leg tremors but did not progress beyond that initial response.

fig. 2.1: Adult pig post-synthesis.

Conclusion: The experiment revealed that Carcinmetalloplastic Stem Cells, specifically the variants of RPC-714-v5 used in this study, were compatible with Artiodactyla mammals such as pigs.

However, the limitation of the experiment became apparent as it was discovered that the pigs' brain structure was not sufficiently developed to facilitate the trigger-phase activation. It was evident that their brain stem lacked the necessary modifications to activate the trigger-phase effectively.

Notes: This is rather troubling. RPC-714's inability to synthesize with lower-intelligence mammals means that we'll have to go back to resorting to CSD-testing. I'll take a meeting with the board of Ethical Reviews to continue the Carcinmetalloplastic experiment program.

—Dr. Thomas Christen

[+] Experiment Log 714/17

	Anomaly Experimentation Team Official Test Log
Location: Site-██	Date: 03/21/2021
Test Subject(s): RPC-714-1-44, RPC-714-1-53, RPC-714-1-55	Classification level: 2
Researchers: Senior Researcher Dr. Thomas Christen, Dr. Attila Kosztolányi, Dr. Ferenc Bachmann, Herta Kafka

[+] Experiment Log 714/18

[-] Experiment Log 714/18

	Anomaly Experimentation Team Official Test Log
	Location: Site-██	Date: 11/02/2022
	Test Subject(s): CSD-4758, CSD-5848, CSD-5848, CSD-3422, (5) RPC-714-v8	Classification level: 2
	Researchers: Senior Researcher Dr. Thomas Christen, Dr. William Woodsworth, Dr. Samuel Shelley, Peter Jacobsen

Experiment 714/18

Resources: CSD-4758 (RPC-714-56), CSD-5848 (RPC-714-58), CSD-7675 (RPC-714-60), RPC-714-v8

Purpose: The purpose of this experiment is to observe the effect of different doses of RPC-714 on human subjects.

Procedure: 5 different RPC-714-v8 samples are to be injected into CSD subjects, each with differing quantities of RPC-714. The sample dosage is as follows:

Sample A: 4.0 million stem cells / 60 ml (control group)
Sample C: 0.8 million stem cells / 60 ml (underdose)
Sample E: 9 million stem cells / 60 ml (overdose)

Subjects will be monitored for any anomalous changes post-injection for the next 4 months. Each subject will be given special treatment according to their metabolic need.

Log: Subject CSD-4758 (RPC-714-56) was given Sample A. After 2 months, RPC-714-56 successfully synthesized RPC-714, exhibiting the expected bone and muscle density. Upon a shock stimulus, RPC-714-56 triggered the transformation phase and manifested dagger blades from its fingers. No significant adverse effects were noted.

Subject CSD-5848 (RPC-714-58) was given Sample B. RPC-714-58 wasn’t able to fully synthesize RPC-714 after 4 months. The low dosage led to RPC-714-58 undergoing osteoporosis. When exposed to a shock stimulus, RPC-714-58's bones prematurely fractured but didn’t heal. The subject was later diagnosed with stage 2 brain cancer.

Subject CSD-3422 (RPC-714-60) was given Sample C. RPC-714-59 fully synthesized RPC-714 after 3 weeks. The subject's body mass grew by 1600%. The subject's brain stem underwent significant modification, resulting in profound mental retardation and the inability to feel pain. Shock stimuli yielded no observable response.

Approximately ██% of the subject's bones, including the skull, have been fractured and transformed into various bladed weapons, protruding out of the subject's flesh. It is unknown how RPC-714-60 managed to survive in this state for ██ months.

Analysis: The subject that was underdosed, despite being given a similar high-protein as CSD-4758, was unable to maintain its cell's conversion into Carcinmetalloplastic tissue. CSD-3422, on the other hand, has undergone significant transformation in the brain stem, resulting in the body perpetually being stuck on a trigger-phase.

Notes: CSD-3422's ability to survive so much modification is interesting. It doesn't seem like we've scratched the surface of the limit the human body can take RPC-714 before immediately dying, and it's possible that the recommended dosage we rely upon results in a watered-down version of the RPC-714-1 instances the Church of Malthus employs.

What's more, I find it curious, is that 4.0 million cells seem to be the universal dosage for anyone regardless of size, health, sex, and age. It appears that the Church of Malthus was careful in crafting the optimal template when creating RPC-714.

—Dr. Thomas Christen

Addendum 714.3: History Log

RPC-714 was initially created in Austro-Hungary in 1914, with the creation of Version 1-2 templates by Dr. ███ Kaufmann, who aimed to engineer super-soldiers for the Great War. These early attempts proved unsuccessful, resulting in the death and permanent disfigurement of subjects injected with the variant.

Advancements in RPC-714 continued, leading to the emergence of Version 3 in 1942. This was the first stable variant and gained widespread distribution by anonymous sects of the Church of Malthus in Eastern Europe. In 1946, Version 4 was developed and quickly became the most commonly used iteration of RPC-714, as transformation is no longer permanent and subjects can retract their weapons back.

[+] Interview Log 22/05/13-714.1

[-] Interview Log 22/05/13-714.1

Interview Log: 22/05/16-714.1

Interviewed: Agent K████

Interview Organizer: Dr. Thomas Christen

Foreward: This interview log is an excerpt from a statement provided by Agent █████, in regards to his tenure as a mercenary for the Sayaad Brigade between 2004 and 2006. The statement is part of a larger investigation into the activities of the Church of Malthus's involvement in the Iraq War. The interview was conducted on May 22nd, 2013, from 13:30 to 15:42.

<Play Log, [14:03]>

Agent K████: …“Weapon-vampires"… yeah, that sounds about right. I became one of them back when I was in the Sayaad Brigade around ten years ago.

Dr. Christen: Was the Sayaad Brigade affiliated with the Church of Malthus?

Agent K████: We weren’t exactly Malthus-aligned. You see, back then, the militia was only a small part of their organization, so they had to hire a lot of mercenaries to do their dirty work. The company I was a part of was the Iraqi sect's main buyer for any bio-weapons they created. I guess you could call us their premium-guinea pig.

Dr. Christen: I see. Can you elaborate on how you became an RPC-714-1 instance?

Agent K████: Back in 2005, our commander, ████████, briefed us on this new transferable mutation the church created for us. He brought this cultist with him, the son of a friend apparently. He was some young kid from Wisconsin, can’t be more than 15. He was there to demonstrate this “new miracle strand”.

Dr. Christen: Interesting…

Agent K████: With his bare fingernails, he tore off his wrist, and in an instant, half a dozen iron daggers and Uzis protruded out of each of his arms. He took a deep breath, and his arm shifted back to normal. Suffice it to say, a bunch of us were impressed and volunteered to take the injection.

Dr. Christen: Do you remember which version of RPC-714 it was?

Agent K████: It was version 6, the zweihander and AK-47 variants. The ones I got aren't as advanced as the ones you guys have now. The pain post-injection was unbearable. It was like my bones suddenly fractured into a pile of needles stinging my muscles. They gave us a shit ton of drugs to cope with it, but it was never enough.

Dr. Christen: When was the first time you entered the trigger-phase?

Agent K████: Somewhere in 2006, during the civil war.⁸ We were contracted to raid some rivaling Malthus sect called ██ ███████ to recover what they called "an important asset". They didn't tell us what it was, just that we'll know when we see it. There were only 20 of us "weapon-vampires", and there were hundreds of ███████ cultists. I tried to tell them it was impossible, but they wouldn't budge and forced us to take on the mission anyways.

I triggered for the first time in that mission, and it felt… natural. As if my radius was always the receiver barrel of an AK, or that my ulma was always the length of my body. Zweihanders aren't meant to be held with just one arm, let alone your forearm, but I instantly adapted to it as my spine mangled itself to balance the two massive swords sticking out of me. Like a drunken man, I began laughing hysterically at my butchered arms. I laughed so hard that I started choking and gasping for air, and after that, my mind went blank.

When I came back to my senses, I was on top of a pile of mutilated bodies covered with oil and shit. My mouth tasted of blood. There were hundreds of them, but now what's left of them are half-eaten carcasses left to rot in the sun.

We eventually found the guy we were supposed to retrieve. He… It was one of us, but not quite. The only thing that was clear to me, was that it wasn't human. It was wearing a large coat to conceal its large frame but I could see the outline of three different pairs of arms with blades attached to them, and large lumps of tumors pulsating in every crevice of its skin. When it noticed our horrified faces, it laughed and twisted itself until it looked human enough.

We asked it if it wanted a ride, but it refused, instead congratulating us for a job well done. It gave us a warm smile, and I can't help but get the sense that it was proud of us, like a father who just saw his baby walk for the first time. It gave us all an awkward hug and pat on the back before walking off into the desert distance. A few minutes later, we got a call and got our pay.

[THIS SECTION OF THE INTERVIEW IS REDACTED]

Dr. Christen: How often were you using RPC-714?

Agent K████: Not as much as I thought I would. If you can't guess already, most of us would rather carry an actual weapon than turn ourselves into flesh-eating beasts with the intelligence of a toddler. Not to mention, most of us have other kinds of bodily modifications implanted in us already. Not as extreme as RPC-714 of course, but I found them a lot more useful.

Dr. Christen: What exactly was the Church of Malthus's purpose in creating RPC-714, if it is, as you claim, more convenient to use weapons?

Agent K████: Beats me. Those cultists aren't right in the head, as brilliant as they are. They have to make a grand show out of everything and go the extra mile. Though, I must admit, it was a bit terrifying when I encountered an enemy RPC-714-1 for the first time.

The Bastard grafted six other arms unto himself and started blasting everywhere, took nine of us before putting the animal down from its misery. It's one thing to face off against another man, but these things they've created are modern predators atop us in the food chain.

<End Log, [14:11]>

Closing Statement: In response to Agent K████'s statement, the Authority undertook a thorough investigation to identify former members of the Sayaad Brigade who might have knowledge about the Carcinmetalloplasia program. The Authority attempted to follow several potential leads in the matter, but those individuals either could not be located or went into hiding before they could be questioned.

Despite repeated attempts, RPC-███ has refused to cooperate with the Authority on matters pertaining to the Sayaad Brigade or the Carcinmetalloplasia program. As a result, the investigation into the Carcinmetalloplasia program remains ongoing.

Research Staff:

Dr. Emil Kaufmann - Head Researcher
Dr. Thomas Christen - Senior Researcher
Dr. William Woodsworth - Assistant Head Researcher
Dr. Samuel Shelley - Lead Biological Researcher
Dr. Ferenc Bachmann - Lead Psychiatric Expert
Dr. Attila Kosztolányi - Assistant Psychiatric Expert
██████████ - Lead Research Investigator

Peter Jacobsen - Research Assistant // Biological
Mary Heine - Research Assistant // Biological
Dr. Attila Kosztolányi - Research Assistant // Psychiatric
Herta Kafka - Research Assistant // Psychiatric
████████████ - Research Assistant // Investigative

[+] Show Footnotes

« RPC-713 | RPC-714 | RPC-715 »

page revision: 15, last edited: 05 Mar 2024 22:13

Edit Rate (+4.8) Tags Discuss (5) History Files Print Site tools + Options

RPC Authority

Research, Protection, Containment

Abstract:

Safe Handling and Usage:

Description:

Biology Department

Overview of the Physiology of RPC-714

Anomaly Experimentation Team Official Test Log

Experiment 714/16

Anomaly Experimentation Team Official Test Log

Experiment 714/17

Anomaly Experimentation Team Official Test Log

Experiment 714/18